Other bulletins in this series include:

Breast Surgery

Monday 16 December 2013

Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma

Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma: An observation study. BMC Anesthesiology, Dec 2013, 13:48.

Deng, S., et al.

http://www.biomedcentral.com/content/pdf/1471-2253-13-48.pdf

Procalcitonin (PCT) is a reliable biomarker of sepsis and infection. The level of PCT 
associated with sepsis and infection in patients with traumatic brain injury is currently 
unknown. The purpose of this study was to investigate the value of PCT and C-reactive 
protein (CRP) as diagnostic markers of sepsis and to evaluate the prognostic value of these 
markers related to the severity of injury, sepsis and mortality

No comments: